Tri-Pase-16 16,000 UNT / 60,000 UNT / 60,000 UNT Oral Tablet
RxNorm 1089863
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1089863 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Tri-Pase-16 16,000 UNT / 60,000 UNT / 60,000 UNT Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Amylase 60000 UNT / lipase 16000 UNT / protease 60000 UNT Oral Tablet [Tri-Pase]
(Atom ID: 12367571)
SY
Synonym (SY):
Tri-Pase (amylase 60,000 UNT / protease 60,000 UNT / lipase 16,000 UNT) Oral Tablet
(Atom ID: 11845964)
SY
Synonym (SY):
Tri-Pase (amylases 60,000 UNT / endopeptidases 60,000 UNT / lipase 16,000 UNT) Oral Tablet
(Atom ID: 11845963)
PSN